gets for DBS. Although the motor outcomes after STN and GPi DBS are similar, apparently, non-motor factors could affect the target selection. In addition, although both STN and GPi stimulation markedly improve postural instability and gait disorder (PIGD), contradicting studies have revealed that patients experienced more frequent falls and gait disturbance in the first 3 months postoperatively (4). Moreover, some long-term studies reported that the gait function worsened in patients with PD undergoing STN DBS (13,16,17,22,23). For instance, █ INTRODUCTION I n patients with advanced idiopathic Parkinson's disease (PD), deep brain stimulation (DBS) is a well-established treatment option. Previously, randomized studies have revealed that treatment with subthalamic nucleus (STN) DBS is superior to the best medical therapy for improving the motor function and quality of life for patients with advanced PD (8). Both STN and globus pallidus interna (GPi) are accepted tar-AIM: To compare the effects of subthalamic nucleus (STN) and globus pallidus interna (GPi) deep brain stimulation (DBS) on the motor outcome, gait and balance function, fall risk (FR), and non-motor symptoms in patients with advanced Parkinson's disease (PD). MATERIAL and METHODS: We randomized patients with advanced PD with the indication of DBS to undergo either STN or GPi DBS and followed them for 2 years. We collected data at baseline and postoperative 6, 12, and 24 months. We compared changes in the Unified Parkinson's Disease Rating Scale (UPDRS) score, timed gait tests, posturography, non-motor symptom questionnaire (NMSQuest), hospital anxiety and depression (HAD) scale, and levodopa equivalent dose (LED). RESULTS: We enrolled and randomized 12 patients to receive either STN (n = 6) or GPi (n = 6) DBS. Postoperative motor outcomes were significantly improved in both groups (p<0.05). In both groups, timed gait tests exhibited better performance in mobility; however, patients receiving GPi DBS performed better than those receiving STN DBS in the timed gait tests (p<0.05). Furthermore, the posturographic evaluation demonstrated a significant elevation in the FR in the STN group (p<0.05). CONCLUSION: Both STN and GPi DBS are equally effective in alleviating disabling motor complications. However, seemingly, STN DBS could cause more gait and balance problems; hence, a tailored approach seems to be more appropriate in the target selection.